Prostate cancer patients on statins have better outcomes after radiotherapy
Saturday, May 8th, 2010 Posted in radiation therapy | No Comments »There is a large collection of evidence to suggest that men who are on long-term statin therapy (with drugs like simvastatin, atorvastatin/Lipitor, or rosuvastatin/Crestor) are at lower risk for prostate cancer and do better than average in terms of treatment ...
New data about radiation therapy for treatment of prostate cancer
Friday, April 23rd, 2010 Posted in radiation therapy | No Comments »Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) provided today advice and recommendations to the Centers for Medicare and Medicaid Services for what is covered by Medicare and Medicaid, based on scientific evidence. Today's meeting focused on the risks, benefits ...
New targeted treatment for prostate cancer
Sunday, April 18th, 2010 Posted in radiation therapy | 3 Comments »University of Cincinnati announced that its researchers will investigate, with a new partnership with Areva Med, the use of a new drug in stopping the growth of prostate cancer tumors. In the study, researchers will test the efficacy of a ...
Interventional radiology treatments for recurrent prostate cancer
Monday, April 12th, 2010 Posted in radiation therapy | No Comments »A new study at Mayo Clinic in Rochester, Minn. suggests that magnetic resonance-guided ablation may prove to be a promising new treatment for prostate cancer recurrences; it tailors treatment modality (imaging) and duration to lesion size and location and provides ...
Undetectable PSA level following prostate brachytherapy
Wednesday, April 7th, 2010 Posted in radiation therapy | No Comments »A recent article in the on-line UroToday International Journal suggests that brachytherapy can (and perhaps should) use a higher standard for long-term follow-up. To evaluate clinical success and failure after brachytherapy most centers today use the Phoenix criteria that defines biochemical ...
Arc radiotherapy treatments: Breakthrough in image-guided targeting of prostate tumors
Saturday, March 6th, 2010 Posted in radiation therapy | No Comments »Researchers at Stanford University (California, USA) and Aarhus University Hospital (Aarhus, Denmark), partially supported by Varian Medical Systems (NYSE: VAR), have made a breakthrough in image-guided targeting of prostate tumors during arc radiotherapy treatments. The research team has devised a ...
Metastasis after radical prostatectomy or external beam radiotherapy for
Monday, March 1st, 2010 Posted in prostatectomy, radiation therapy | No Comments »A study at Memorial Sloan-Kettering Cancer Center, New York, assessed the effect of radical prostatectomy and external beam radiotherapy on distant metastases rates in patients with localized prostate cancer treated with radical prostatectomy or external beam radiotherapy at a single ...
Stereotactic body radiotherapy for organ-confined prostate cancer
Thursday, February 11th, 2010 Posted in radiation therapy | No Comments »Urologists suggest that the potential to reduce treatment-related morbidity and maintain quality of life following prostate cancer treatment will depend by improved understanding of prostate cancer radiobiology combined with advances in delivery of radiation to the moving prostate offer A recent ...
Management of prostate cancer recurrence after definitive radiation therapy
Monday, February 8th, 2010 Posted in radiation therapy | No Comments »The management of prostate cancer recurrence after definitive radiation therapy is shifting and there is no consensus regarding the optimal strategy. The major challenge is determining the anatomical site of relapse. In case of biochemical relapse, androgen deprivation therapy is ...
Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy
Sunday, January 24th, 2010 Posted in hormone therapy, radiation therapy | No Comments »Discrepancies exist regarding the impact of neoadjuvant hormone therapy (NHT) on the risk of all-cause mortality (ACM) in men who receive brachytherapy for localized prostate cancer. Therefore, the latest study at Harvard Radiation Oncology Program, Boston, Massachusetts targeted to examine ...